» Articles » PMID: 32020066

How Many Rare Diseases Are There?

Citing Articles

A global survey about undiagnosed rare diseases: perspectives, challenges, and solutions.

Baldovino S, Sciascia S, Carta C, Salvatore M, Cellai L, Ferrari G Front Public Health. 2025; 13:1510818.

PMID: 40078755 PMC: 11897027. DOI: 10.3389/fpubh.2025.1510818.


Mapping variants in thyroid hormone transporter MCT8 to disease severity by genomic, phenotypic, functional, structural and deep learning integration.

Groeneweg S, van Geest F, Martin M, Dias M, Frazer J, Medina-Gomez C Nat Commun. 2025; 16(1):2479.

PMID: 40075072 PMC: 11904026. DOI: 10.1038/s41467-025-56628-w.


A Comparison of Transfer Learning Metaphyseal Sign Diagnostic Models for Kashin-Beck Disease Based on X-rays of Children's Hands.

Li G, Zhang H, Chen P, Song Y, Zhang Y, Li C Cureus. 2025; 17(1):e78235.

PMID: 40027020 PMC: 11871940. DOI: 10.7759/cureus.78235.


International Precision Child Health Partnership (IPCHiP): an initiative to accelerate discovery and improve outcomes in rare pediatric disease.

Howell K, White S, McTague A, DGama A, Costain G, Poduri A NPJ Genom Med. 2025; 10(1):13.

PMID: 40016282 PMC: 11868529. DOI: 10.1038/s41525-025-00474-8.


Integrating Machine Learning-Based Approaches into the Design of ASO Therapies.

Leckie J, Yokota T Genes (Basel). 2025; 16(2).

PMID: 40004514 PMC: 11855077. DOI: 10.3390/genes16020185.


References
1.
Oprea T, Bologa C, Brunak S, Campbell A, Gan G, Gaulton A . Unexplored therapeutic opportunities in the human genome. Nat Rev Drug Discov. 2018; 17(5):317-332. PMC: 6339563. DOI: 10.1038/nrd.2018.14. View

2.
Haendel M, Chute C, Robinson P . Classification, Ontology, and Precision Medicine. N Engl J Med. 2018; 379(15):1452-1462. PMC: 6503847. DOI: 10.1056/NEJMra1615014. View

3.
Tambuyzer E, Vandendriessche B, Austin C, Brooks P, Larsson K, Miller Needleman K . Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat Rev Drug Discov. 2019; 19(2):93-111. DOI: 10.1038/s41573-019-0049-9. View